Poly(ethylene glycol) modified poly(2-hydroxypropylene imine) as efficient reagent for siRNA transfection
详细信息 查看全文
- 作者：Alma Bockuviene ; Juste Balciunaite ; Kristina Slavuckyte…
- 关键词：PEG’ylation ; Polyimine ; Cationic polymer ; Transfection ; siRNA
- 刊名：Journal of Polymer Research
- 出版年：2016
- 出版时间：January 2016
- 年：2016
- 卷：23
- 期：1
- 全文大小：975 KB
- 参考文献：1.Boucher RC (1999) Clin Investig 103:441–445CrossRef
2.Cavazzana-Calvo M, Hacein-Bey S, de Saint BG, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Science 669:669–672CrossRef
3.Merdan T, Kopeček J, Kissel TJ (2002) Adv Drug Deliv Rev 54:715–758CrossRef
4.Li W, Szoka FC (2007) Pharm Res 3:438–449CrossRef
5.LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin AJ (2011) Lancet Neurol 10:309–319CrossRef
6.Resnier P, Montier T, Mathieu V, Benoit J, Passirani C (2013) Biomaterials 34:6429–6443CrossRef
7.Gould DJ, Favorov P (2003) Gene Ther 10:912–927CrossRef
8.Stone D, David A, Bolognani F, Lowenstein PR, Castro MG (2000) J Endocrinol 164:103–118CrossRef
9.Lundstrom K (2003) Trends Biotechnol 21:117–122CrossRef
10.Yang J, Liu H, Zhang X (2014) Biotechnol Adv 32:804–817CrossRef
11.Mintzer MA, Simanek EE (2009) Chem Rev 109:259–302CrossRef
12.Agarwal S, Zhang Y, Maji S, Greiner A (2012) Mater Today 15:388–393CrossRef
13.Synatschke CV, Schallon A, Jerome V, Freitag R, Muller AHE (2011) Biomacromolecules 12:4247–4255CrossRef
14.Kurosaki T, Yamashita Y, Aki K, Harasawa H, Nakagawa H, Kodama Y, Higuchi N, Nakamura T, Kitahara T, Sasaki HJ (2011) Pharm Sci 100:4855–4863CrossRef
15.Wu Y, Liu C, Zhao X, Xiang J (2008) J Polym Res 15:181–185CrossRef
16.Baker A, Saltik M, Lehrmann H, Killisch I, Mautner V, Lamm G, Christofori G, Cotten M (1997) Gene Ther 4:773–782CrossRef
17.Szabo R, Mezo G, Hudecz F (2002) J Bioact Compat Polym 17:399–415CrossRef
18.Dubruel P, Christiaens B, Vanloo B, Bracke K, Rosseneu M, Vandekerckhove J, Schacht (2003) Eur J Pharm Sci 18:211–220CrossRef
19.Ahmed M, Jawanda M, Ishihara K, Narain R (2012) Biomaterials 33:7858–7870CrossRef
20.Wu C, Liu C, Hao J, Deng X (2010) J Polym Res 17:869–876CrossRef
21.Wightman L, Kircheis R, Rossler V, Carotta S, Ruzicka R, Kursa M, Wagner E (2001) J Gene Med 3:362–372CrossRef
22.Lungwitz U, Breunig M, Blunk T, Gopferich A (2005) Eur J Pharm Biopharm 60:247–266CrossRef
23.Von Harpe A, Petersen H, Li Y, Kissel T (2000) J Control Release 69:309–322CrossRef
24.Jager M, Schubert S, Ochrimenko S, Fischer D, Schubert US (2012) Chem Soc Rev 41:4755–4767CrossRef
25.Zhang S, Zhao B, Jiang H, Wang B, Ma B (2007) J Control Release 123:1–10CrossRef
26.Hu Y, Tang G, Liu J, Cheng W, Yue Y, Li J, Zhang P (2012) J Biomed Biotechnol 2012:1–7
27.Ngyugen HK, Lemieux P, Vinogradov SV, Gebhart CL, Guerin N, Paradis G, Bronich TK, Alakhov VY, Kabanov AV (2000) Gene Ther 7:126–138CrossRef
28.Liu Y, Nguyen J, Steele T, Merkel O, Kissel T (2009) Polymer 50:3895–3904CrossRef
29.Xun M, Liu Y, Guo Q, Zhang J, Zhang Q, Wu W, Yu X (2014) Eur J Med Chem 78:118–125CrossRef
30.Rimann M, Luhmann T, Textor M, Guerino B, Ogier J, Hall H (2008) Bioconjug Chem 19:548–557CrossRef
31.Kolate A, Baradia D, Patil S, Vhora I, Kore G, Misra A (2014) J Control Release 192:67–81CrossRef
32.Zintchenko A, Philipp A, Dehshahri A, Wagner E (2008) Bioconjug Chem 19:1448–1455CrossRef
33.Roberts MJ, Bentley MD, Harris JM (2002) Adv Drug Deliv Rev 54:459–476CrossRef
34.Petersen H, Fechner PM, Fischer D, Kissel T (2002) Macromolecules 35:6867–6874CrossRef
35.Zhang X, Pan S, Hu H, Wu G, Feng M, Zhang W, Luo X (2008) J Biomed Mater Res 84A:795–804CrossRef
36.Banerjee P, Weissleder R, Bogdanov AJ (2006) Chem Bioconjug 17:125–131CrossRef
37.Petersen H, Kunath K, Martin AL, Stolnik S, Roberts CJ, Davies MC, Kissel T (2002) Biomacromolecules 3:926–936CrossRef
38.Parka MR, Hanb KO, Hanb IK, Cho MH, Nahd JW, Choia YJ, Choa CS (2005) J Control Release 105:367–380CrossRef
39.Kursa M, Walker GF, Roessler V, Ogris M, Roedl W, Kircheis R, Wagner E (2003) Bioconjug Chem 14:222–231CrossRef
40.Zhong Z, Feijen J, Lok MC, Hennink WE, Christensen LV, Yockman JW, Kim YH, Kim SW (2005) Biomacromolecules 6:3440–3448CrossRef
41.Mao S, Neu M, Germershaus O, Merkel O, Sitterberg J, Bakowsky U, Kissel T (2006) Bioconjug Chem 17:1209–1218CrossRef
42.Shen Y, Deng J, Luo X, Zhang X, Zeng X, Feng M, Pan S (2009) J Biomater Sci 20:1217–1233CrossRef
43.Malek A, Czubayko F, Aigner A (2008) J Drug Target 16:124–139CrossRef
44.Gary DJ, Puri N, Won YJ (2007) Control Release 121:64–73CrossRef
45.Mady MM, Mohammed WA, El-Guendy NM, Elsayed AA (2011) Rom J Biophys 2:151–165
46.Boussif O, Lezoualcht F, Zanta MA, Mergnyt MD, Schermant D, Demeneixt B, Behr (1995) J Proc Natl Acad Sci 92:7297–7301CrossRef
47.Ohlfest JR, Perkinson S, Lobitz P, Hasz D, Largaespada DA (2004) Mol Ther 10:260–268CrossRef
48.Aravindana L, Bicknella KA, Brooks G, Khutoryanskiy VV, Williams AC (2009) Int J Pharm 378:201–210CrossRef
49.Zaliauskiene L, Bernadisiute U, Vareikis A, Makuska R, Volungeviciene I, Petuskaite A, Riauba L, Lagunavicius A, Zigmantas S (2010) Bioconjug Chem 21:1602–1611CrossRef
50.Lagunavicius A, Zigmantas S, Riauba L, Zaliauskiene L, Makuska R, Vareikis A (2010) Bernadisiute U US Patent Application 12/333,453
51.Bernadisiute U, Antanelis T, Vareikis A, Makuska R (2008) Chemija 19:43–49
52.Bockuviene A, Vareikis A, Makuska R (2015) Chemija 26:51–59
53.Wang J, Lu Z, Wientjes MG, Au JLS (2010) AAPS J 12:492–503CrossRef
54.Odian G (2004) Principles of polymerization, Fourth ed., John Wiley & Sons, Inc. Chapter 2, pp 39–195
55.Malmström E, Hult A (1997) J Macromol Sci C Polym Rev 37:555–579
56.Benjaminsen RV, Mattebjerg MA, Henriksen JR, Moghimi SM, Andresen TL (2013) Mol Ther 21:149–157CrossRef
57.Sonawane ND, Szoka FC, Verkman AS (2003) J Biol Chem 278:44826–44831CrossRef
58.Boussif O, Lezoualc’h F, Zanta MA (1995) Proc Natl Acad Sci U S A 92:7297–7301CrossRef
59.Godbey WT, Kenneth KW, Mikos AG (1999) J Biomed Mater Res 45:268–275CrossRef
60.Erbacher P, Rem J-S, Behr J-P (1999) Gene Ther 6:138–145CrossRef
61.Knorr V, Allmendinger L, Walker GF, Paintner FF, Wagner E (2007) Bioconjug Chem 18:1218–1225CrossRef - 作者单位：Alma Bockuviene (1)
Juste Balciunaite (1)
Kristina Slavuckyte (2)
Lolita Zaliauskiene (2)
Ausvydas Vareikis (1)
Ricardas Makuska (1)
1. Department of Polymer Chemistry, Vilnius University, Naugarduko 24, LT-03225, Vilnius, Lithuania
2. Thermo Fisher Scientific Baltics, Graiciuno 8, LT-02241, Vilnius, Lithuania - 刊物类别：Chemistry and Materials Science
- 刊物主题：Chemistry
Polymer Sciences
Industrial Chemistry and Chemical Engineering
Characterization and Evaluation Materials - 出版者：Springer Netherlands
- ISSN：1572-8935
文摘
MPEG’ylated poly(2-hydroxypropylene imines) were synthesised using 1,3-diamino-2-propanol, 1,3-dibromo-2-propanol and methoxy poly(ethylene glycol) (MPEG, Mn 1000, 2000, 5000). Trying to find conditions favourable for attachment of MPEG chains, MPEG iodide was either added to the initial mixture of the monomers (method A), or was introduced later, at the end of the reaction (method B). MPEG’ylated derivatives of PHPI were characterized by FTIR and NMR spectroscopy, SEC, DLS, DSC and potentiometric titration and were tested for DNA and siRNA delivery in vitro. Efficiency of high MW / low MPEG content PHPI derivatives in DNA transfection was similar to that of PHPI. MPEG grafting had a positive effect on siRNA delivery: high MW polymers with low content of MPEG performed significantly better than non-MPEG’ylated PHPI and low-molecular-weight polymers with high content of MPEG. The length of MPEG chains attached to the polymers had no effect over the transfection efficiency.